Literature DB >> 14607235

Study on inclusion interaction of piroxicam with beta-cyclodextrin derivatives.

Guo Xiliang1, Yang Yu, Zhao Guoyan, Zhang Guomei, Chao Jianbin, Shuang Shaomin.   

Abstract

The inclusion behavior of piroxicam (PX) with beta-cyclodextrin (beta-CD), hydroxypropyl-beta-cyclodextrin (HP-beta-CD), and carboxymethyl-beta-cyclodextrin (CM-beta-CD) was investigated by using steady-state fluorescence and nuclear magnetic resonance (NMR) technique. The various factors affecting the inclusion process were examined in detail. The remarkable fluorescence emission enhancement upon addition of CDs suggested that cyclodextrins (CDs) were most suitable for inclusion of the uncharged species of PX. The stoichiometry of the PX-CDs inclusion complexes was 1:1, except for beta-CD where a 1:2 inclusion complex was formed. The formation constants showed the strongest inclusion capacity of beta-CD. NMR showed the inclusion mode of PX with CDs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607235     DOI: 10.1016/s1386-1425(03)00164-1

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  3 in total

1.  Influence of cyclodextrin complexation with NSAIDs on NSAID/cold stress-induced gastric ulceration in rats.

Authors:  Ibrahim A Alsarra; Mahrous O Ahmed; Fars K Alanazi; Kamal Eldin Hussein Eltahir; Abdulmalik M Alsheikh; Steven H Neau
Journal:  Int J Med Sci       Date:  2010-07-05       Impact factor: 3.738

2.  Understanding Surface Interaction and Inclusion Complexes between Piroxicam and Native or Crosslinked β-Cyclodextrins: The Role of Drug Concentration.

Authors:  Giuseppina Raffaini; Fabio Ganazzoli
Journal:  Molecules       Date:  2020-06-19       Impact factor: 4.411

3.  Enzymatic activity enhancement of non-covalent modified superoxide dismutase and molecular docking analysis.

Authors:  Yan-Zi Qiu; Zong-Hua Huang; Fa-Jun Song
Journal:  Molecules       Date:  2012-03-30       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.